Select Page

Research Studies

RAD is a research facility committed to advancing the field of fertility. Our clinical trials offer the most advanced treatment available in addition to benefits such as free or significantly reduced costs for study medications and treatment.

Endometriosis & Pelvic Pain Center Observational Study

RAD is currently seeking new patients to participate in an Endometriosis & Pelvic Pain Center Observational Study. This study will describe historic, current, and evolving treatment pathways, treatments, and interventions in women with a suspected or confirmed diagnosis of endometriosis in order to better understand the impact of early intervention on the disease or its symptoms. Length of treatment is dependent on standard of care treatment provided and all study information will be collected during routine standard of care visits.

Please note the study is not open to current or past patients at this time. There are no study medications associated with this research trial. Your plan of care remains the same if you are a participant in the study or not.

You may be eligible to participate if you:

  • are of reproductive age (between their first menstrual cycle and before onset of menopause).
  • have experienced chronic pelvic pain (CPP) and/or dysmenorrhea (DYS) for at least 6 months prior to enrollment without symptom improvement with non-steroidal anti-inflammatory drugs (NSAIDs) or hormone/medical treatment.
  • are a woman with suspected or confirmed endometriosis (EM) at time of enrollment.
  • are a woman with CPP and/or DYS impacting daily activities as determined by their treating physician.
  • are able to read, understand and respond to patient questionnaires.
  • are willing to sign a patient authorization and/or informed consent form (ICF) and agree to disclose personal health information.

To learn more about this study, visit clinicaltrials.gov here.

Please note that this is not an infertility or IVF study.

Contact Mark Modelski at mmodelski@radfertility.com for more information.

University of Delaware Research Study

RAD is collaborating with the Physiology Core Lab at the University of Delaware for a research study examining estrogen effects on blood vessel function in women.

You may be eligible to participate if you are:

  • Female between 18-30 years old
  • Have normal blood pressure
  • Have no history of heart disease or diabetes
  • Maintain normal weight and do not use tobacco
  • Study involves taking Antagon and Estrogen

The study requires 5 visits to the laboratory (about 14 hours total).

Please note that this is not an infertility or IVF study.

Participants will receive up to $375 for their time. Contact Mark Modelski by email at mmodelski@radfertility.com for more information.

CLOSED - IVF Clinical Trial 2019
RAD is currently seeking patients to participate in an IVF clinical trial. This is a great opportunity for some of our patients who are contemplating IVF to attain their family building dreams. In addition to helping us advance the field of fertility, participants who qualify will enjoy benefits like free or significantly reduced costs for study medications and treatment.

You may be eligible to participate if you are:

  • You are between 18-42 years of age
  • Your body mass index (BMI) is between 17.5 and 38.0
  • You currently have regular menstrual cycles
  • You are preparing to undergo an IVF cycle with a fresh embryo transfer

To learn more about this study, visit clinicaltrials.gov here and here

CLOSED - IVF Clinical Trial 2018

RAD is currently seeking patients to participate in an IVF clinical trial. In addition to helping us advance the field of fertility, participants who qualify will enjoy benefits like free or significantly reduced costs for study medications and treatment. We have additional research opportunities on the horizon that will start in Fall 2018.

Learn more about this study, visit clinicaltrials.gov

CLOSED - IVF Clinical Trial 2017

Reproductive Associates of Delaware is currently seeking patients to participate in a fertility research study designed to compare two medications used for controlled ovarian stimulation (COS), in in vitro fertilization (IVF) cycles.

The study medications and some study-related tests and procedures may be provided at no cost to qualified participants.

You may be eligible for the study if you:

  • Are between 21-35 years old
  • Have a regular menstrual cycle of 21 to 45 days
  • Have a history of infertility and desire pregnancy
  • Have an AMH (Anti-Mullerian Hormone) ≥ 5 (ng/mL)

Your decision to participate in the study is voluntary and deciding not to participate will not change your care at Reproductive Associates of Delaware.

To learn more about this study along with exclusion criteria, visit clinicaltrials.gov

CLOSED - LutrePulse Hypogonadotropic Hypogonadism Clinical Research Study

Reproductive Associates of Delaware is participating in the LutrePulse Clinical Research Study. The study is evaluating the ovulation rate in women after receiving an investigational pulsatile gonadotropin-releasing hormone (GnRH) medication. The study requires patients that meet the following criteria.

 

  • You are a woman 18-40 years old
  • You have a clinical history or were recently diagnosed with primary amenorrhea with hypogonadotropic hypogonadism
  • You desire to become pregnant

 

CLOSED - AMH Study

RAD is currently seeking patients to participate in a research study by donating a blood sample that will help evaluate a test that measures Anti-Müllerian hormone (AMH). AMH is a naturally occurring hormone found in both men and women. In women, AMH, is related to the reproductive cycle and the ability to get pregnant, and may help identify women who may have problems getting pregnant because of poor ovarian response.

Eligible participants will be compensated as a result of their volunteer participation in this study.

If you are currently planning to undergo your 1st, 2nd, or 3rd cycle of ovarian stimulation for IVF, you may be eligible to participate in this research study if you meet the following eligibility:

  • You are between the ages of 21 and 45 years old.
  • You have regular menstual cycles (between 21 and 35 days).
  • You have both of your ovaries.
  • You are not currently on oral contraceptives.
  • You do not have confirmed PCOS.
  • You have not had any ovarian surgery within the last year.
  • You have not recently had drug or radiation treatment for cancer.
  • You are not currently pregnant
  • You are willing to provide a blood sample according to the research study.

IVF Programs

Request an Appointment

If you would like to schedule an appointment, please let us know which dates and times work for you. A Patient Navigator will contact you to confirm your appointment.

Take Our Fertility Assessment

Answer a few brief questions and receive a personal response. Every submission is reviewed by a fertility expert. Get the answers you are looking for today! 

Get To Know Mark Modelski

Research Coordinator

Being the research coordinator at RADfertility is the job I’ve always wanted. Seeing how RAD makes happy families and being able to use what I’ve learned in school to help our patients be successful in our research program is very satisfying.

As RAD’s research coordinator, I help recruit and interact with patients to provide guidance and support for our study opportunities and what is expected at each visit.

I look forward to meeting with you, and strive to always provide the best care for you as we explore the latest research opportunities at RAD together.

Contact Mark by email at mmodelski@radfertility.com

Free Second Opinion Consult

Call (302) 602-8822 to speak to one of our Patient Navigators and schedule your free second opinion consult. Please mention this offer when you call.

Where You Go For Fertility Care Really Matters

For over two decades, we have followed the golden rule of fertility care: offering the same treatment to you that we would want for our friends and loved ones.

IVF For ME™

Maximizing IVF success with preimplantation genetic testing for aneuploidies (PGT-A).

PreciousEggs™

We are a leader in fresh and frozen egg technology that helps grow families.

EmbryoScope®

Time-lapse video allows our IVF experts to analyze individual embryo growth.

Single Embryo Transfer

RAD has one of the highest SET and pregnancy rates in the country.

IVF Success Rates

We lead the way through research and innovation contributing to nationally recognized success.

Nicole C. G.

★★★★★

"We had a wonderful experience working with RADfertility. Our doctor was so sweet, informative and helpful with all of our questions. The front desk, it’s always nice to be greeted by a friendly smiling face."

Jessica

★★★★★

"RAD heard my hopes, dreams, and wishes and led me toward them while holding my hand. My dream came true. I was guided to a beautiful baby girl! It took less than a year for my pregnancy to begin and it was successful. This was the best decision I ever made. Thank you, RAD!"

Christa C.

★★★★★

"From the beginning our team was determined to find a way for my husband and I to complete our family. All the RAD staff was knowledgeable and truly cared for us. We wish we could have continued with them after our baby hit 12 weeks. We thank them daily in our prayers for giving us our beautiful baby girl!"

Shaun

★★★★★

"We will be forever grateful for the wonderful care we received at RAD! Dr. Feinberg took the time to listen and create a plan we were comfortable with. The whole team was amazing and truly care about their patients. You have exceeded our expectations. Thank you!!"

Jaqueline M.

★★★★★

"Thanks to RADfertility, we have the most perfect addition to our family. The help and support the whole staff gave us was indescribable. We never once lost hope because of them. We will be forever grateful to each and every person we worked with during our journey."

Hira

★★★★★

"Dr. Neithardt was amazing. She explained in great detail all the options we had and put us at ease about the entire process. Everyone has been amazing and I have absolutely no complaints. Today I am 17 weeks pregnant and we only have Dr. Neithardt and her wonderful team at RAD to thank."

Michelle H.

★★★★★

"They are the most amazing team of doctors and care coordinators. After having started at another facility I was so happy to come to RAD. They are truly amazing, never make you feel like just a number and have empathy and compassion every step of the way. They also get the job done! Thanks RAD!"

Anonymous On FertilityIQ

★★★★★

"Dr. McGuirk is a very holistic doctor. She doesn’t just treat the fertility issues. She also points out personal health ideas (juicing, whole 30) to help heal/treat the whole patient. She is honest and open. Be open minded and trust in her process. This is a marathon, not a sprint! Dr. McGuirk will be with you the whole way."

Teresa P.

★★★★★

"I will never be able to put into words how thankful we are for RAD. Rhonda was there every step of the way as we were going through the process. Everyone was so welcoming and patient as we asked questions. We were blessed with a daughter, who is now three. I have already recommended and will continue to recommend RAD to people who need help growing their family!"

Newark Office

4735 Ogletown-Stanton Road
Medical Arts Pavilion 2
Suite 3217
Newark, DE 19713

Wilmington Office

Silverside Medical Center
2700 Silverside Road, Suite 2A
Wilmington, DE 19810

Dover Office

Eden Hill Medical Center
200 Banning Street, Suite 240
Dover, DE 19904

Phone: (302) 602-8822

Fax: (302) 602-8832

©RADfertility 2020